Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ligelizumab for Chronic Spontaneous Urticaria.
Maurer M, Giménez-Arnau AM, Sussman G, Metz M, Baker DR, Bauer A, Bernstein JA, Brehler R, Chu CY, Chung WH, Danilycheva I, Grattan C, Hébert J, Katelaris C, Makris M, Meshkova R, Savic S, Sinclair R, Sitz K, Staubach P, Wedi B, Löffler J, Barve A, Kobayashi K, Hua E, Severin T, Janocha R. Maurer M, et al. Among authors: sussman g. N Engl J Med. 2019 Oct 3;381(14):1321-1332. doi: 10.1056/NEJMoa1900408. N Engl J Med. 2019. PMID: 31577874 Free article. Clinical Trial.
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.
Harris JM, Cabanski CR, Scheerens H, Samineni D, Bradley MS, Cochran C, Staubach P, Metz M, Sussman G, Maurer M. Harris JM, et al. Among authors: sussman g. J Allergy Clin Immunol. 2016 Dec;138(6):1730-1732. doi: 10.1016/j.jaci.2016.06.023. Epub 2016 Jul 19. J Allergy Clin Immunol. 2016. PMID: 27567329 Clinical Trial. No abstract available.
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study.
Maurer M, Giménez-Arnau A, Bernstein JA, Chu CY, Danilycheva I, Hide M, Makris M, Metz M, Savic S, Sitz K, Soong W, Staubach P, Sussman G, Barve A, Burciu A, Hua E, Janocha R, Severin T. Maurer M, et al. Among authors: sussman g. Allergy. 2022 Jul;77(7):2175-2184. doi: 10.1111/all.15175. Epub 2021 Nov 22. Allergy. 2022. PMID: 34773261 Free article. Clinical Trial.
Management and treatment of chronic urticaria (CU).
Maurer M, Church MK, Gonçalo M, Sussman G, Sánchez-Borges M. Maurer M, et al. Among authors: sussman g. J Eur Acad Dermatol Venereol. 2015 Jun;29 Suppl 3:16-32. doi: 10.1111/jdv.13198. J Eur Acad Dermatol Venereol. 2015. PMID: 26053292
Controversies and challenges in the management of chronic urticaria.
Staubach P, Zuberbier T, Vestergaard C, Siebenhaar F, Toubi E, Sussman G. Staubach P, et al. Among authors: sussman g. J Eur Acad Dermatol Venereol. 2016 Jul;30 Suppl 5:16-24. doi: 10.1111/jdv.13696. J Eur Acad Dermatol Venereol. 2016. PMID: 27286499 Review.
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria.
Kolkhir P, Altrichter S, Asero R, Daschner A, Ferrer M, Giménez-Arnau A, Hawro T, Jakob T, Kinaciyan T, Kromminga A, Konstantinou GN, Makris M, Metz M, Skov PS, Staubach P, Sussman G, Zhang K, Maurer M. Kolkhir P, et al. Among authors: sussman g. Allergy Asthma Immunol Res. 2021 Jul;13(4):545-559. doi: 10.4168/aair.2021.13.4.545. Allergy Asthma Immunol Res. 2021. PMID: 34212543 Free PMC article.
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
Schoepke N, Asero R, Ellrich A, Ferrer M, Gimenez-Arnau A, E H Grattan C, Jakob T, Konstantinou GN, Raap U, Skov PS, Staubach P, Kromminga A, Zhang K, Bindslev-Jensen C, Daschner A, Kinaciyan T, Knol EF, Makris M, Marrouche N, Schmid-Grendelmeier P, Sussman G, Toubi E, Church MK, Maurer M. Schoepke N, et al. Among authors: sussman g. Allergy. 2019 Dec;74(12):2427-2436. doi: 10.1111/all.13949. Epub 2019 Jul 29. Allergy. 2019. PMID: 31228881
223 results